Trait centric view

1. Trait name:	Udder cleft
   Ontology terms:	VT:1000702, CMO:0000416

   152 genes are associated with this trait, with QTL/association found

   • AAGAB: Alpha and gamma adaptin binding protein
     evidenced by: QTL:44367;
   • ACOXL: Acyl-CoA oxidase like
     evidenced by: QTL:45074;
   • ACSS3: Acyl-CoA synthetase short chain family member 3
     evidenced by: QTL:40774;
   • ADAM10: ADAM metallopeptidase domain 10
     evidenced by: QTL:44755;
   • ADAM2: ADAM metallopeptidase domain 2
     evidenced by: QTL:53548;
   • ADAMTS16: ADAM metallopeptidase with thrombospondin type 1 motif 16
     evidenced by: QTL:50956;
   • ADAMTS17: ADAM metallopeptidase with thrombospondin type 1 motif 17
     evidenced by: QTL:50965;
   • ADAMTS6: ADAM metallopeptidase with thrombospondin type 1 motif 6
     evidenced by: QTL:50608;
   • ADCY3: Adenylate cyclase 3
     evidenced by: QTL:45554; QTL:45568;
   • AMOT: Angiomotin
     evidenced by: QTL:54709;
   • ANXA4: Annexin A4
     evidenced by: QTL:45046;
   • AP3B1: Adaptor-related protein complex 3, beta 1 subunit
     evidenced by: QTL:44339;
   • ARHGAP10: Rho GTPase activating protein 10
     evidenced by: QTL:48703;
   • ARHGEF12: Rho guanine nucleotide exchange factor 12
     evidenced by: QTL:47858;
   • ASB5: Ankyrin repeat and SOCS box containing 5
     evidenced by: QTL:53330;
   • ATP1A3: ATPase Na+/K+ transporting subunit alpha 3
     evidenced by: QTL:49742;
   • BCAS3: BCAS3 microtubule associated cell migration factor
     evidenced by: QTL:50034;
   • BMP5: Bone morphogenetic protein 5
     evidenced by: QTL:51983;
   • BTBD11: BTB domain containing 11
     evidenced by: QTL:41144; QTL:41155;
   • BTD: Biotinidase
     evidenced by: QTL:38994;
   • C3H1ORF87: Chromosome 3 C1orf87 homolog
     evidenced by: QTL:40023;
   • C8B: Complement C8 beta chain
     evidenced by: QTL:40072;
   • CACNA1D: Calcium channel, voltage-dependent, L type, alpha 1D subunit
     evidenced by: QTL:125925;
   • CACNA1H: Calcium channel, voltage-dependent, T type, alpha 1H subunit
     evidenced by: QTL:125927;
   • CAPN3: Calpain 3, (p94)
     evidenced by: QTL:44598; QTL:44615;
   • CCDC141: Coiled-coil domain containing 141
     evidenced by: QTL:39055;
   • CDH6: Cadherin 6
     evidenced by: QTL:50307;
   • CFAP43: Cilia and flagella associated protein 43
     evidenced by: QTL:52836;
   • CGNL1: Cingulin like 1
     evidenced by: QTL:44775;
   • CHRM3: Cholinergic receptor muscarinic 3
     evidenced by: QTL:53725; QTL:53743;
   • COBLL1: Cordon-bleu WH2 repeat protein like 1
     evidenced by: QTL:39243;
   • COL12A1: Collagen type XII alpha 1 chain
     evidenced by: QTL:51969;
   • COL4A1: Collagen type IV alpha 1 chain
     evidenced by: QTL:46574;
   • CPAMD8: C3 and PZP like alpha-2-macroglobulin domain containing 8
     evidenced by: QTL:42683;
   • CPQ: Carboxypeptidase Q
     evidenced by: QTL:47692;
   • CREBBP: CREB binding protein
     evidenced by: QTL:125928;
   • CRTC1: CREB regulated transcription coactivator 1
     evidenced by: QTL:42650;
   • CSAD: Cysteine sulfinic acid decarboxylase
     evidenced by: QTL:40841;
   • CSGALNACT1: Chondroitin sulfate N-acetylgalactosaminyltransferase 1
     evidenced by: QTL:53599;
   • CTNNA3: Catenin alpha 3
     evidenced by: QTL:53772;
   • DHX36: DEAH-box helicase 36
     evidenced by: QTL:38706;
   • DTNA: Dystrobrevin alpha
     evidenced by: QTL:52363;
   • DYSF: Dysferlin
     evidenced by: QTL:45164;
   • EIF2B3: Eukaryotic translation initiation factor 2B subunit gamma
     evidenced by: QTL:40197;
   • FAS: Fas (TNF receptor superfamily, member 6)
     evidenced by: QTL:52661;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51702; QTL:51730;
   • FLT4: Fms related receptor tyrosine kinase 4
     evidenced by: QTL:42631;
   • FNDC3B: Fibronectin type III domain containing 3B
     evidenced by: QTL:38645;
   • FRYL: FRY like transcription coactivator
     evidenced by: QTL:42062;
   • FUT10: Fucosyltransferase 10
     evidenced by: QTL:53473;
   • GABARAPL1: GABA(A) receptor-associated protein like 1
     evidenced by: QTL:173305;
   • GALNT2: Polypeptide N-acetylgalactosaminyltransferase 2
     evidenced by: QTL:53654;
   • GALNT6: Polypeptide N-acetylgalactosaminyltransferase 6
     evidenced by: QTL:125923;
   • GANC: Glucosidase alpha, neutral C
     evidenced by: QTL:44584;
   • GC: Group-specific component (vitamin D binding protein)
     evidenced by: QTL:95583;
   • GOLT1A: Golgi transport 1A
     evidenced by: QTL:48064;
   • GPHN: Gephyrin
     evidenced by: QTL:44951;
   • GRB2: Growth factor receptor bound protein 2
     evidenced by: QTL:50146;
   • GRIA3: Glutamate ionotropic receptor AMPA type subunit 3
     evidenced by: QTL:54180; QTL:54199;
   • GRID2: Glutamate ionotropic receptor delta type subunit 2
     evidenced by: QTL:314316;
   • HPSE2: Heparanase 2 (inactive)
     evidenced by: QTL:52771;
   • HSD17B12: Hydroxysteroid (17-beta) dehydrogenase 12
     evidenced by: QTL:47983;
   • KCNIP1: Potassium voltage-gated channel interacting protein 1
     evidenced by: QTL:50366;
   • KCTD2: Potassium channel tetramerization domain containing 2
     evidenced by: QTL:50160;
   • KMT2A: Lysine methyltransferase 2A
     evidenced by: QTL:47851;
   • LETM1: Leucine zipper and EF-hand containing transmembrane protein 1
     evidenced by: QTL:42569;
   • LMO7: LIM domain 7
     evidenced by: QTL:46427;
   • LOC282685: Rhesus-like protein
     evidenced by: QTL:39653;
   • LRP2: Low density lipoprotein receptor-related protein 2
     evidenced by: QTL:28162;
   • MACROD2: MACRO domain containing 2
     evidenced by: QTL:28165; QTL:43704;
   • MAOB: Monoamine oxidase B
     evidenced by: QTL:54928;
   • MAPKBP1: Mitogen-activated protein kinase binding protein 1
     evidenced by: QTL:44555;
   • MBNL3: Muscleblind like splicing regulator 3
     evidenced by: QTL:54325;
   • MEF2C: Myocyte enhancer factor 2C
     evidenced by: QTL:43360;
   • MID1: Midline 1
     evidenced by: QTL:55502;
   • MOCS1: Molybdenum cofactor synthesis 1
     evidenced by: QTL:52015;
   • MRC2: Mannose receptor C type 2
     evidenced by: QTL:49990;
   • MSGN1: Mesogenin 1
     evidenced by: QTL:45672;
   • MYBPC1: Myosin binding protein C, slow type
     evidenced by: QTL:40996;
   • NALCN: Sodium leak channel, non-selective
     evidenced by: QTL:46544;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:38386; QTL:45766;
   • NCOA1: Nuclear receptor coactivator 1
     evidenced by: QTL:45581;
   • NCSTN: Nicastrin
     evidenced by: QTL:39725;
   • NDP: Norrin cystine knot growth factor NDP
     evidenced by: QTL:54911;
   • NELFA: Negative elongation factor complex member A
     evidenced by: QTL:42604;
   • NHS: NHS actin remodeling regulator
     evidenced by: QTL:55249;
   • NMUR1: Neuromedin U receptor 1
     evidenced by: QTL:39633;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53798; QTL:53815; QTL:53832;
   • NSD2: Nuclear receptor binding SET domain protein 2
     evidenced by: QTL:42587;
   • NT5E: 5'-nucleotidase, ecto (CD73)
     evidenced by: QTL:44090;
   • OSBPL10: Oxysterol binding protein like 10
     evidenced by: QTL:51569;
   • OSR1: Odd-skipped related transcription factor 1
     evidenced by: QTL:45635;
   • OTOP3: Otopetrin 3
     evidenced by: QTL:50174;
   • PAK5: P21 (RAC1) activated kinase 5
     evidenced by: QTL:46636;
   • PEA15: Proliferation and apoptosis adaptor protein 15
     evidenced by: QTL:39740;
   • PER2: Period circadian regulator 2
     evidenced by: QTL:40314;
   • PHEX: Phosphate regulating endopeptidase homolog X-linked
     evidenced by: QTL:55162; QTL:55176;
   • PHF2: PHD finger protein 2
     evidenced by: QTL:43729;
   • PHKA2: Phosphorylase kinase regulatory subunit alpha 2
     evidenced by: QTL:55228;
   • PKHD1: PKHD1, fibrocystin/polyductin
     evidenced by: QTL:125926;
   • PLA2G4F: Phospholipase A2 group IVF
     evidenced by: QTL:44571;
   • PLCD3: Phospholipase C delta 3
     evidenced by: QTL:50062;
   • PRDM16: PR domain containing 16
     evidenced by: QTL:48342;
   • PRIM2: DNA primase subunit 2
     evidenced by: QTL:51910;
   • PRKG1: Protein kinase, cGMP-dependent, type I
     evidenced by: QTL:52650;
   • PTPRR: Protein tyrosine phosphatase, receptor type R
     evidenced by: QTL:137185;
   • RAB15: RAB15, member RAS oncogene family
     evidenced by: QTL:44935;
   • RAB20: RAB20, member RAS oncogene family
     evidenced by: QTL:28166;
   • RAD51: RAD51 recombinase
     evidenced by: QTL:44478;
   • RAD54B: RAD54 homolog B
     evidenced by: QTL:47719;
   • RASA3: RAS p21 protein activator 3
     evidenced by: QTL:46586;
   • RBMS1: RNA binding motif single stranded interacting protein 1
     evidenced by: QTL:39381;
   • RCAN2: Regulator of calcineurin 2
     evidenced by: QTL:52137;
   • REN: Renin
     evidenced by: QTL:48050;
   • RFX4: Regulatory factor X4
     evidenced by: QTL:41110;
   • RNF157: Ring finger protein 157
     evidenced by: QTL:50096;
   • ROCK2: Rho associated coiled-coil containing protein kinase 2
     evidenced by: QTL:45912;
   • RPAP1: RNA polymerase II associated protein 1
     evidenced by: QTL:44544;
   • RSPO2: R-spondin 2
     evidenced by: QTL:47659;
   • SERINC3: Serine incorporator 3
     evidenced by: QTL:47363;
   • SLC25A13: Solute carrier family 25 member 13
     evidenced by: QTL:40340;
   • SLC39A10: Solute carrier family 39 member 10
     evidenced by: QTL:39484;
   • SLC6A1: Solute carrier family 6 member 1
     evidenced by: QTL:51839;
   • SLIT3: Slit guidance ligand 3
     evidenced by: QTL:50346;
   • SMOC1: SPARC related modular calcium binding 1
     evidenced by: QTL:44963;
   • SNX29: Sorting nexin 29
     evidenced by: QTL:52517;
   • SPRED2: Sprouty related EVH1 domain containing 2
     evidenced by: QTL:45502;
   • SRGAP2: SLIT-ROBO Rho GTPase activating protein 2
     evidenced by: QTL:48110;
   • SRP68: Signal recognition particle 68
     evidenced by: QTL:50111;
   • SUSD4: Sushi domain containing 4
     evidenced by: QTL:48261;
   • SYN2: Synapsin II
     evidenced by: QTL:51859;
   • SYN3: Synapsin III
     evidenced by: QTL:41192; QTL:41233;
   • SYTL5: Synaptotagmin like 5
     evidenced by: QTL:54987;
   • TASP1: Taspase 1
     evidenced by: QTL:46771;
   • TEN1: TEN1 subunit of CST complex
     evidenced by: QTL:50126;
   • TIMP2: TIMP metallopeptidase inhibitor 2
     evidenced by: QTL:50079;
   • TMEM87B: Transmembrane protein 87B
     evidenced by: QTL:45056;
   • TRIM68: Tripartite motif containing 68
     evidenced by: QTL:47904;
   • TTN: Titin
     evidenced by: QTL:125921;
   • TTYH2: Tweety family member 2
     evidenced by: QTL:50203;
   • UBE2E2: Ubiquitin conjugating enzyme E2 E2
     evidenced by: QTL:53621;
   • UBR1: Ubiquitin protein ligase E3 component n-recognin 1
     evidenced by: QTL:44628; QTL:44642;
   • UNC5D: Unc-5 netrin receptor D
     evidenced by: QTL:53520;
   • USP13: Ubiquitin specific peptidase 13
     evidenced by: QTL:38583;
   • VDR: Vitamin D receptor
     evidenced by: QTL:137182;
   • VPS28: VPS28, ESCRT-I subunit
     evidenced by: QTL:47446;
   • WDFY3: WD repeat and FYVE domain containing 3
     evidenced by: QTL:42474; QTL:42489;
   • XRCC4: X-ray repair cross complementing 4
     evidenced by: QTL:43321; QTL:43335;
   • ZBP1: Z-DNA binding protein 1
     evidenced by: QTL:47310;
   • ZKSCAN8: Zinc finger with KRAB and SCAN domains 8
     evidenced by: QTL:52189;
   • ZNF280D: Zinc finger protein 280D
     evidenced by: QTL:44788;
   • ZNF891: Zinc finger protein 891
     evidenced by: QTL:49236;
   397 correlations are found involving Udder cleft